Surg Cosmet Dermatol. 2017;9(3):269-271
Vitiligo is a hypopigmentation disorder that is characterized by macules and selective destruction of functional epidermal melanocytes. It is characterized by defilements and circumscribed depigmented patches. Vitiligo affects around 0,5% about 0.5% -2% of the general population worldwide, and is not observed preference for sex and ethnicity. The goals of treatment are repigmentation of vitiligo and stabilization of depigmentation process. We report the case of a 53-year-old female patient who underwent underwent experimental stem cell therapy with autologous biologically expanded stem cells isolated from hair follicle, holding three sessions with three months apart. The vitiligo affected area was relatively decreased in density with a rare repigmentation pattern.
Keywords: STEM CELLS; VITILIGO; THERAPEUTICS
All content the journal, except where identified, is under a Creative Commons Attribution-NonCommercial 4.0 International license - ISSN-e 1984-8773
